D-0643-2025 Class II Ongoing
FDA drug recall D-0643-2025 was initiated by AvKARE on Aug 25, 2025 and is designated Class II. Reason for recall: Presence of a foreign substance. The recall status is ongoing. Affected quantity: 1512 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 17, 2025
- Initiation Date
- Aug 25, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1512 cartons
Product description
chloroproMAZINE Hydrochloride Tablets, USP, 50 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC 50268-164-15
Reason for recall
Presence of a foreign substance.
Distribution pattern
USA Nationwide
Code information
Lot # 46824, Exp 9/30/25; 47171, Exp 12/31/25
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0643-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026